Mark Altmeyer - Net Worth and Insider Trading
Mark Altmeyer Net Worth
The estimated net worth of Mark Altmeyer is at least $94,568 dollars as of 2024-09-21. Mark Altmeyer is the Director of Myovant Sciences Ltd and owns about 3,500 shares of Myovant Sciences Ltd (MYOV) stock worth over $94,430. Mark Altmeyer is also the Pres&Chief Commercial Officer of Sio Gene Therapies Inc and owns about 288 shares of Sio Gene Therapies Inc (SIOX) stock worth over $138. Details can be seen in Mark Altmeyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mark Altmeyer has not made any transactions after 2017-11-17 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Mark Altmeyer
Mark Altmeyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Altmeyer owns 2 companies in total, including Myovant Sciences Ltd (MYOV) , and Sio Gene Therapies Inc (SIOX) .
Click here to see the complete history of Mark Altmeyer’s form 4 insider trades.
Insider Ownership Summary of Mark Altmeyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2017-11-17 | director |
| SIOX | Sio Gene Therapies Inc | 2016-03-10 | Pres&Chief Commercial Officer |
Mark Altmeyer Latest Holdings Summary
Mark Altmeyer currently owns a total of 2 stocks. Among these stocks, Mark Altmeyer owns 3,500 shares of Myovant Sciences Ltd (MYOV) as of November 17, 2017, with a value of $94,430 and a weighting of 99.85%. Mark Altmeyer also owns 288 shares of Sio Gene Therapies Inc (SIOX) as of March 10, 2016, with a value of $138 and a weighting of 0.15%.
Latest Holdings of Mark Altmeyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MYOV | Myovant Sciences Ltd | 2017-11-17 | 3,500 | 26.98 | 94,430 |
| SIOX | Sio Gene Therapies Inc | 2016-03-10 | 288 | 0.48 | 138 |
Holding Weightings of Mark Altmeyer
Mark Altmeyer Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark Altmeyer has made a total of 0 transactions in Myovant Sciences Ltd (MYOV) over the past 5 years. The most-recent trade in Myovant Sciences Ltd is the acquisition of 3,500 shares on November 17, 2017, which cost Mark Altmeyer around $46,830.
According to the SEC Form 4 filings, Mark Altmeyer has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 288 shares on March 10, 2016, which cost Mark Altmeyer around $25,622.
Insider Trading History of Mark Altmeyer
- 1
Mark Altmeyer Trading Performance
GuruFocus tracks the stock performance after each of Mark Altmeyer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark Altmeyer is 23.07%. GuruFocus also compares Mark Altmeyer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark Altmeyer within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark Altmeyer's insider trading performs compared to the benchmark.
Performance of Mark Altmeyer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.46 | | | | | |
| Relative Return to S&P 500(%) | -5.8 | | | | | |
Mark Altmeyer Ownership Network
Mark Altmeyer Owned Company Details
What does Myovant Sciences Ltd do?
Who are the key executives at Myovant Sciences Ltd?
Mark Altmeyer is the director of Myovant Sciences Ltd. Other key executives at Myovant Sciences Ltd include 10 percent owner Sumitomo Chemical Co., Ltd. , Chief Commercial Officer Lauren Merendino , and General Counsel & Corp. Secy. Matthew Lang .
Myovant Sciences Ltd (MYOV) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Myovant Sciences Ltd (MYOV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Myovant Sciences Ltd (MYOV) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Myovant Sciences Ltd (MYOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Myovant Sciences Ltd Insider Transactions
Mark Altmeyer Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Altmeyer. You might contact Mark Altmeyer via mailing address: C/o Axovant Sciences, Inc., 1441 Broadway, 3rd Floor, New York Ny 10018.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
